Navigation Links
Landauer, Inc. Increases Regular Cash Dividend and Declares First Quarter Payment
Date:11/26/2008

GLENWOOD, Ill., Nov. 26 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR) announced today that its Board of Directors increased the regular quarterly cash dividend by 5% to $0.525 per share for the first quarter of fiscal 2009. This increase represents an annual rate of $2.10 per share compared with $2.00 last year. The dividend will paid on January 2, 2009 to shareholders of record on December 12, 2008.

About Landauer

Landauer is the leading provider of analytical services to determine occupational and environmental radiation exposure. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings.


'/>"/>
SOURCE Landauer, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Landauer, Inc. Declares Regular Cash Dividend
2. Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results
3. Landauer, Inc. Declares Regular Cash Dividend
4. Landauer, Inc. Reports Record Results for Second Quarter
5. Landauer, Inc. Declares Regular Cash Dividend
6. Landauer, Inc. Declares Regular Cash Dividend
7. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2008 Results
8. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
9. Fat on chest and upper back increases risk of insulin resistance
10. Handling Stress Properly Increases Good Cholesterol
11. High alcohol consumption increases stroke risk among Chinese men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Source ... botanicals and 100 percent pure essential oils, announced the company had a successful visit ... , The annual ECRM event gives companies that work in the nutritional, sports and ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Bionic Sports ... all walks of life, announced it had a successful January ECRM Trade Show in ... in the United States, which allows it to provide its products to all clients ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based company ... attended the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding ... range of supplements that keep the body functioning at its peak performance by ...
(Date:1/20/2017)... boca raton florida (PRWEB) , ... January 20, 2017 , ... ... trial at the Dana Farber Cancer Institute. For Betsy, the clinical trial has ... and her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... CITY, Calif. , Jan. 19, 2017  Abaxis, ... company manufacturing point-of-care blood analysis instruments and consumables for ... conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on ... results for the third quarter fiscal year 2017 after ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, Inc. ... company specializing in the treatment of non-melanoma skin ... with superficial radiation therapy, today announced that it ... 2016 financial results on Thursday, February 2, 2017 after ... hold a conference call with the investment community ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
Breaking Medicine Technology: